Search
-
PM takes to stage in Davos as migration worries persist at home
PoliticsGreek Politics. “It’s just not fair.” Mitsotakis set out how he believes the EU can address this imbalance. “As we come
4% -
Poll shows support for ND in several policy areas as pension bill debate heats up
PoliticsGreek Politicsthan the current 60 percent, someone who is insured for one job will not have to pay a second set
4% -
ND targets NGOs in latest bid to bring migration under control
PoliticsGreek Politicswhether the uprising of migrants on Lesvos this week was set in motion by others. The inference
4% -
Newsletter 238 -07/02/2020
of migrants on Lesvos this week was set in motion by others. The inference was that NGOs with ulterior
4% -
Tensions within SYRIZA en route to membership ballot, party conference
PoliticsGreek PoliticsTensions have flared up among rival factions in SYRIZA, as the main opposition party tries to find its footing against the New Democracy government and stake out a territory in the post-MoU political landscape. The ongoing internal debate looks set to run over the coming weeks, with a number of key
4% -
ND steps up efforts to build island detention centres for migrants
PoliticsGreek Politics, Migration Policy Minister Notis Mitarakis said that a Returns Directorate would be set up as part
4% -
Strong performance of 15-year bond bodes well for market strategy
Economythis positive momentum in Greek yields sets the right tone for the primary surplus goal, which is set
4% -
SYRIZA looks back at time in office as it searches for way forward
PoliticsGreek Politicsperformance during the previous years, it does set out many of the party’s failings, some due
4% -
New businesses lowest in Greece versus EU with funding obstacles burdening enterprises
EconomyFeatures, Greece has remained in bottom place since 2015, the year for which the data set first became
4% -
Latest Novartis clash signals deeper battle over role of judiciary
PoliticsGreek Politicstried to set up SYRIZA’s rivals by claiming they had received bribes from the pharmaceutical giant
4%